Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, announced today that Kenneth C. Frazier, Merck’s chairman and chief executive officer, is scheduled to present at the 32ndAnnual J.P. Morgan Healthcare Conference in San Francisco on January 13 at 4:00 p.m. PST (7:00 p.m. EST). Merck & Co., Inc. (NYSE:MRK) stock opened at $49.82 in last trading session, and closed at $49.75, trading in the range of $49.34 – $50.00. The stock showed a positive weekly performance of 0.06%.
Pfizer Inc. (NYSE:PFE) was downgraded by investment analysts at Cowen and Company from an “outperform” rating to a “market perform” rating in a note issued to investors on Friday, TheFlyOnTheWall.com reports. Pfizer Inc. (NYSE:PFE) shares closed at $30.75 on last trade day, by -0.06%. Stock 52 week range is $26.34 – $32.50. Company’s market capitalization is $199.52 billion.
Today Eli Lilly & Co. (NYSE:LLY) Diabetes announced it will renew its commitment to the Diabetes Scholars Foundation (Foundation) scholarship fund for another two years. The commitment includes a $200,000 donation ($100,000 for each calendar year) that will support the Foundation’s mission: to empower young people with type 1 diabetes to live their lives to the fullest. Eli Lilly & Co. (NYSE:LLY) finished the last session at $51.49. The EPS of the stock remained 4.38. Company’s market capitalization is $58.00 billion.
Johnson & Johnson (NYSE:JNJ) was downgraded by research analysts at Goldman Sachs Group Inc. from a “neutral” rating to a “sell” rating in a report released on Tuesday, American Banking & Market News reports. Johnson & Johnson (NYSE:JNJ) stock opened at $94.94 in last trading session and closed at $94.64. The 52 week range of the stock is $71.74 – $95.99 and the day range was $94.09 – $95.38.
Leave a Reply